Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
Sleep Med ; 66: 168-173, 2020 02.
Article in English | MEDLINE | ID: mdl-31884409

ABSTRACT

BACKGROUND/OBJECTIVE: The first line treatment for obstructive sleep apnea (OSA) is nasal continuous positive airway pressure (nCPAP), for which a variety of masks are available. While nasal masks (NM) are the first choice; oronasal masks (ONM) are also frequently used to prevent mouth dryness resulting from mouth opening. Our cross-sectional, prospective, randomized, un-blinded study addressed the efficacy of wearing an oral shield in addition to NM in preventing mouth leakage METHODS: Patients with OSA and established therapy using NM and complaining about mouth dryness (n = 29) underwent three polysomnographies (PSGs) using NM, ONM or a nose mask in combination with an oral shield (NMS). Mask leakage was continuously documented and objective sleep quality was assessed. RESULTS: There were significant differences in the apnea-hypopnea-index (AHI) between ONM (8.5/h; SD 6,7) and NM/nasal mask combined with oral shield device (NMS) (2.6/h; SD 2,3; 2.7/h; SD 2,6) (p < 0,05) as well as in leakage [ONM (39.7 l/min SD 12,4); NM (34.6 l/min SD 9,4); NMS (33.1 l/min SD 9,6)] (p = 0.011). Furthermore, analysis of sleep quality (NREM3) favored NM and NMS over ONM (p = 0.02). There were no significant differences between NM and NMS in any objective outcome. CONCLUSIONS: Our data consistently confirmed the NM as the first choice for continuous positive airway pressure (CPAP) therapy of OSA. Notably, we demonstrated a high potential of the oral shield for patients with mouth opening to achieve additional comfort and thereby possibly compliance, without affecting nCPAP therapy effectiveness.


Subject(s)
Continuous Positive Airway Pressure , Equipment Design , Masks , Mouth , Sleep Apnea, Obstructive/therapy , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Patient Compliance , Polysomnography , Prospective Studies
3.
J Cardiovasc Pharmacol ; 47(3): 450-5, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16633089

ABSTRACT

Akrinor (AKR), a mixture of theodrenaline (TDR) and cafedrine (CDR), is a sympathomimetic agent used to counter transitory hypotension. Although some cases of vascular complications associated with AKR have been reported there are no experimental data about its direct effects on coronary arteries. The effects of AKR, TDR, CDR, and ephedrine (EDR) were studied on the isometric contraction of the ring preparations of pig coronary arteries precontracted with KCl. The influence of endothelium removal and preincubation with nonselective beta-adrenoreceptor antagonist propranolol (PROP), alpha(1)-adrenoreceptor antagonist prazosin, dopamine receptor antagonist SCH 23390, and adenosine receptor antagonist CGS 15943 were also tested. AKR, TDR, and CDR produced relaxation of the preparations. Preparations without endothelium were more sensitive to AKR relaxing effects. EDR produced an increase of vascular ring tonus. AKR, TDR, and EDR produced contraction in preparations pretreated with PROP. Higher concentrations of AKR relaxed PROP-pretreated preparations. AKR-induced contraction could be prevented by pretreatment with prazosin. Dopamine and adenosine receptor antagonists did not influence relaxing effects of AKR. In conclusion, AKR and its constituents induce the relaxation of pig coronary artery preparations precontracted with KCl. The observed contraction in the preparations pretreated with PROP was probably due to stimulation of unmasked alpha(1)-adrenoreceptors.


Subject(s)
Coronary Vessels/drug effects , Propranolol/pharmacology , Receptors, Adrenergic, alpha-1/physiology , Theophylline/analogs & derivatives , Vasodilation/drug effects , Animals , Coronary Vessels/physiology , Drug Combinations , Ephedrine/pharmacology , In Vitro Techniques , Phenylpropanolamine/analogs & derivatives , Phenylpropanolamine/pharmacology , Potassium Chloride/pharmacology , Swine , Theophylline/pharmacology , Vasoconstriction/drug effects
4.
Anesth Analg ; 98(2): 343-345, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14742367

ABSTRACT

UNLABELLED: We tested the effectiveness of the cough trick (CT) as a method of pain relief during peripheral venipuncture (VP) in a crossover study. Twenty healthy volunteers were punctured twice in the same hand vein within an interval of 3 wk, once with the CT procedure and once without it. The intensity of pain, hand withdrawal, palm sweating, blood pressure, heart rate, and serum glucose concentration were recorded. The intensity of pain during VP with the CT procedure was less than without it, whereas the other variables changed insignificantly. The easily performed CT was effective in pain reduction during VP, although the mechanism remains unclear. IMPLICATIONS: The effectiveness of a cough trick for pain reduction during peripheral venipuncture was tested in a volunteer study in which each subject served as his own control. The easily performed cough-trick procedure was effective for pain reduction, although the mechanism remains unclear.


Subject(s)
Cough/physiopathology , Pain/prevention & control , Phlebotomy/adverse effects , Adult , Anxiety/psychology , Blood Pressure/physiology , Cross-Over Studies , Heart Rate/physiology , Humans , Male , Pain/etiology , Pain Measurement , Pilot Projects , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...